Diploma PLC (LON:DPLM) Insider Ian El-Mokadem Acquires 500 Shares of Stock

Posted by Defense World Staff on Mar 26th, 2025

Diploma PLC (LON:DPLM – Get Free Report) insider Ian El-Mokadem purchased 500 shares of the business’s stock in a transaction dated Monday, March 24th. The stock was bought at an average price of GBX 3,948 ($51.11) per share, with a total value of £19,740 ($25,556.71).

Diploma Stock Performance

Shares of DPLM opened at GBX 3,970 ($51.40) on Wednesday. Diploma PLC has a 12-month low of GBX 3,372 ($43.66) and a 12-month high of GBX 4,808 ($62.25). The stock has a market cap of £5.30 billion, a P/E ratio of 45.63, a PEG ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The company has a 50-day moving average of GBX 4,385.96 and a two-hundred day moving average of GBX 4,379.51.

Diploma Increases Dividend

The company also recently announced a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were issued a GBX 42 ($0.54) dividend. This represents a yield of 0.93%. This is a positive change from Diploma’s previous dividend of $17.30. The ex-dividend date of this dividend was Thursday, January 16th. Diploma’s dividend payout ratio is 65.52%.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. raised their price objective on Diploma from GBX 4,370 ($56.58) to GBX 4,420 ($57.22) and gave the company a “neutral” rating in a research note on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Diploma has an average rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($59.13).

Check Out Our Latest Research Report on Diploma

Diploma Company Profile

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.